Newsletters

Top stories in this newsletter:
Hong Kong revised list of notifiable diseases amid the novel coronavirus outbreak
Chinese scientist, who claimed he created the world’s first “gene-edited” babies, jailed for three years
Woman who suffered an eye injury during a Hong Kong protest lost court challenge against police’s refusal to produce warrant for her medical records
Is it ethical to quarantine Chinese cities?

Top stories in this newsletter:
Master of Laws in Medical Ethics and Law
Dismissal of appeal by Hong Kong doctor who did not notice from medical records nurses’ wrongful management
Vague understanding of end-of-life care services in Hong Kong
More research to be done into women’s health problems

Top stories in this newsletter:
Journal article on compulsory mental health treatment co-authored by CMEL’s Deputy Director
Events on medical and healthcare AI postponed
Father whose ex forged his signature to use frozen embryos lost claim
Inquiry into Google’s patient data deal in the United States

Top stories in this newsletter:
Upcoming lecture and conference on AI in medicine and healthcare
Hong Kong Court clarifies the law of gross negligence manslaughter
CMEL’s Deputy Director shares her view on the legal definition of mental incapacity amid advance directive consultation in Hong Kong
Genome sequencing and personalised medicine

Top stories in this newsletter:
Hong Kong Government’s consultation on proposals regarding advance directives and dying in place
Woman who suffered an eye injury during a Hong Kong protest challenges the
police’s refusal to provide a copy of the warrant for her medical records
How the Genetic Information Non-Discrimination Act protects against genetic discrimination in the United States
Impact of Japan’s deregulation of regenerative medicine

Top stories in this newsletter:
Parental order concerning surrogate children granted by the Hong Kong court after considering issues such as delay and breach of the law
US court ordered pharmaceutical giant to pay US$572 million in landmark opioid case